Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving disability benefit take-up: Experimental evidence from a public information campaign in Vietnam.

Journal of health economics·2026
Same author

Emerging biomarkers for early detection of colorectal cancer.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Vaccine-derived T-cell responses are insufficient to generate protective immunity to SARS-CoV-2.

Scientific reports·2026
Same author

Exploring the Impact of Two DNA Minor Groove Binder Compounds on HCT-116 Cells: A Comprehensive Multiomics Analysis Using Mass Spectrometry.

Journal of proteome research·2026
Same author

Untargeted metabolomics profiling of childhood asthma: linking metabolic pattern to disease severity.

Molecular and cellular pediatrics·2026
Same author

Correction: Community-based participatory design of a decade: the FAITH! Cardiovascular Health and Wellness Program.

Frontiers in public health·2026

Related Experiment Video

Updated: Jul 19, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

Streptococcus agalactiae CAMP factor/protein B does not bind to human IgG.

Waseem El-Huneidi1, Ryan Mui, Tian Hua Zhang

  • 1Department of Chemistry, University of Waterloo, Waterloo, ON, N2L 3G1 Canada.

Medical Microbiology and Immunology
|November 7, 2006
PubMed
Summary

Streptococcus agalactiae CAMP factor, also known as protein B, does not bind to immunoglobulin G (IgG). This study found no evidence of interaction between CAMP factor and IgG, contrary to previous reports.

More Related Videos

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Related Experiment Videos

Last Updated: Jul 19, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Area of Science:

  • Microbiology
  • Immunology
  • Protein Biochemistry

Background:

  • CAMP factor is an extracellular cytolytic protein from Streptococcus agalactiae.
  • It has been suggested to bind immunoglobulin G (IgG) Fc fragments, similar to Staphylococcus aureus protein A.
  • This interaction's functional significance, particularly regarding complement activation and hemolytic activity, requires further investigation.

Purpose of the Study:

  • To thoroughly characterize the interaction between Streptococcus agalactiae CAMP factor (protein B) and immunoglobulin G (IgG).
  • To investigate whether CAMP factor influences complement activation mediated by IgG antibodies.
  • To determine if IgG affects the co-hemolytic activity of CAMP factor.

Main Methods:

  • Co-incubation of purified CAMP factor and human IgG.
  • Assessing complement activation on sheep red blood cells using hemolysin antibodies.
  • Evaluating the effect of IgG on CAMP factor's co-hemolytic activity.
  • Gel filtration chromatography to separate CAMP factor and IgG post-incubation.

Main Results:

  • CAMP factor did not inhibit complement activation by hemolysin antibodies, unlike Staphylococcus aureus protein A.
  • IgG did not inhibit the co-hemolytic activity of CAMP factor, contradicting prior findings.
  • Gel filtration demonstrated complete separation of CAMP factor and IgG, indicating no stable complex formation.

Conclusions:

  • Streptococcus agalactiae CAMP factor does not appear to bind immunoglobulin G (IgG).
  • The previously reported binding and associated functional consequences may be inaccurate or context-dependent.
  • Further research is needed to elucidate the precise biological roles of CAMP factor in host-pathogen interactions.